Hindawi Publishing Corporation BioMed Research International Volume 2014, Article ID 960628, 6 pages http://dx.doi.org/10.1155/2014/960628
Clinical Study Partial Splenic Embolization with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma Accompanied by Thrombocytopenia Yoshihiko Ooka, Tetsuhiro Chiba, Sadahisa Ogasawara, Tenyu Motoyama, Eiichiro Suzuki, Akinobu Tawada, Fumihiko Kanai, and Osamu Yokosuka Department of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan Correspondence should be addressed to Tetsuhiro Chiba;
[email protected] Received 2 July 2014; Revised 31 August 2014; Accepted 2 September 2014; Published 15 September 2014 Academic Editor: Satoru Murata Copyright © 2014 Yoshihiko Ooka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. Thrombocytopenia often makes the introduction of systemic treatment difficult in patients with cirrhosis and hepatocellular carcinoma (HCC). We retrospectively evaluated the long-term effects of partial splenic embolization (PSE) with transarterial chemoembolization (TACE) in patients with HCC patients accompanied by thrombocytopenia. Patients and Methods. Twenty-one patients with HCC complicated by severe thrombocytopenia (platelet count,
